Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06607445
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-12
Brief Title:
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service Population Cohort MedeA21
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MedeA
Brief Summary:
An open longitudinal observational study non-randomized which will include the adult population attended by the SES in which preference will be given to those patients under treatment with drugs that can produce relevant adverse effects It is a naturalistic study in which no pharmacological or other type of intervention will be carried out only the information recommended in the drug data sheet pharmacogenetic biomarkers relevant interactions and clinical contraindications will be provided
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None